Compounds > perindopril
Page last updated: 2024-09-02

perindopril and Elevated Cholesterol

perindopril has been researched along with Elevated Cholesterol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Borghi, C; Cicero, AFG; D'Addato, S; Fogacci, F; Giovannini, M; Rizzoli, E1
Dézsi, CA; Simon, A1
Radchenko, G; Sirenko, Y1
Sillence, D; Tchan, M1
Muir, KW1
SoRelle, R1

Other Studies

6 other study(ies) available for perindopril and Elevated Cholesterol

ArticleYear
Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2022, Volume: 32, Issue:9

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Blood Pressure; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Perindopril

2022
Treatment of Hypertensive and Hypercholesterolaemic Patients with the Triple Fixed Combination of Atorvastatin, Perindopril and Amlodipine: The Results of the CORAL Study.
    Advances in therapy, 2019, Volume: 36, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Animals; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Comorbidity; Drug Combinations; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies

2019
Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2017, Volume: 24, Issue:1

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Perindopril; Risk Factors; Time Factors; Treatment Outcome; Ukraine

2017
Fabry disease and Factor V Leiden: a potent vascular risk combination.
    Internal medicine journal, 2011, Volume: 41, Issue:5

    Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defibrillators, Implantable; Drug Therapy, Combination; Enzyme Replacement Therapy; Fabry Disease; Factor V; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metoprolol; Middle Aged; Perindopril; Pyrroles; Quality of Life; Recurrence; Sequence Deletion; Stents; Stroke; Stroke Rehabilitation; Thrombophilia; Warfarin

2011
Secondary prevention for stroke and transient ischaemic attacks.
    BMJ (Clinical research ed.), 2004, Feb-07, Volume: 328, Issue:7435

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypercholesterolemia; Hypertension; Indapamide; Ischemic Attack, Transient; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke

2004
Stenosis and the drug-eluting stent.
    Circulation, 2004, Mar-23, Volume: 109, Issue:11

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Azetidines; Cardiology; Coronary Restenosis; Diabetes Complications; Ezetimibe; Humans; Hypercholesterolemia; Myocardial Infarction; Myocardial Ischemia; Perindopril; Radionuclide Imaging; Randomized Controlled Trials as Topic; Stents

2004